Titan Pharmaceuticals, Inc.

281 articles about Titan Pharmaceuticals, Inc.

• Titan Pharma Schedules Conference Call to Review Third Quarter 2017 Financial Results

  11/6/2017

  The call will be hosted by Sunil Bhonsle, president and CEO; Kate Beebe, Ph.D., executive vice president and chief development officer; Brian Crowley, vice president of finance; and Marc Rubin, M.D., executive chairman.

• Titan Pharmaceuticals Presents Non-Clinical Data From Liothyronine (L-T3) Implant Studies

  10/20/2017

  Titan Pharma announced today the planned presentation of non-clinical data on the use of its ProNeura subdermal implant for the long-term, sustained delivery of liothyronine (L-T3) during a poster session on Oct. 20 at the 87th annual conference of the American Thyroid Association in Victoria, British Columbia, Canada.

• First Patient Treated With Titan Pharma' Subdermal Implant For Parkinson's Disease

  10/11/2017

• Titan Pharma And Opiant Pharma Collaborate To Explore A New Approach To Opioid Use Disorder Treatment

  10/2/2017

• Opiant Pharma And Titan Pharma Collaborate To Explore A New Approach To Opioid Use Disorder Treatment

  10/2/2017

• Titan Pharma Receives FDA Clearance To Begin Clinical Study Of Parkinson's Disease Treatment

  8/24/2017

• Titan Pharma Reports Second Quarter 2017 Financial Results

  8/9/2017

• Titan Pharma Schedules Conference Call To Review Second Quarter 2017 Financial Results

  8/3/2017

• Titan Pharma Secures $10 Million Debt Facility From Horizon Technology Finance

  7/28/2017

• Titan Pharma And Walter Reed Army Institute of Research Collaborate To Evaluate ProNeura Antimalarial Implants

  7/6/2017

• Fortune Article Highlights Titan Pharma And Its ProNeura Technology

  6/29/2017

• Titan Pharma Reports First Quarter 2017 Financial Results

  5/10/2017

• Titan Pharma Schedules Conference Call To Review First Quarter 2017 Financial Results

  5/4/2017

• Titan Pharma Reports Full Year And Fourth Quarter 2016 Financial Results

  3/16/2017

• Titan Pharma Schedules Conference Call To Review Fourth Quarter And Full Year 2016 Financial Results

  3/10/2017

• Titan Pharma Receives FDA Communication On Ropinirole Implant Investigational New Drug Application

  2/28/2017

• Titan Pharma Appoints Two New Board Members

  1/4/2017

• Titan Pharma Reports Third Quarter 2016 Financial Results

  11/10/2016

• Titan Pharma Schedules Conference Call To Review Third Quarter 2016 Financial Results

  11/4/2016

• Titan Pharma Reports Second Quarter 2016 Financial Results

  8/9/2016